# Blinded manuscript-review evaluation

## Evaluation method

Each package was scored independently against G01-G18. A detection required the review to state the ground-truth defect itself; generic requests for more data, adjacent statistical remarks, or a `NOT ASSESSABLE` statement did not count. Unsupported-concern counts were reserved for affirmative defects, results, misconduct claims, external facts, or missing items not supported by the frozen packet. Conditional alternatives, bounded editorial judgments, and explicit non-assessability boundaries were not penalized.

## Score summary

| System | Run | Ground-truth recall | Precision | Traceability | Resolution | Consistency | Journal calibration | Auditability | Total |
|---|---|---:|---:|---:|---:|---:|---:|---:|---:|
| System A | A1 | 30.00 | 20 | 15 | 10 | 8 | 10 | 5 | 98.00 |
| System A | A2 | 30.00 | 20 | 15 | 10 | 8 | 10 | 5 | 98.00 |
| System B | B1 | 30.00 | 20 | 15 | 10 | 9 | 9 | 2 | 95.00 |
| System B | B2 | 27.86 | 20 | 15 | 10 | 9 | 9 | 2 | 92.86 |

### System A, run A1

A1 detects all 18 answer-key issues. Its final verdict accurately concentrates the decisive leakage, treatment-selection, single-cell, perturbation, animal, endpoint, reproducibility, ethics, reference, generalizability, survival-model, figure-reporting, and Nature-fit defects. The ledger and matrix supply stable IDs, manuscript anchors, adjudication, resolution tests, journal gates, and validation evidence, justifying full traceability, resolution, journal-calibration, and auditability scores.

Consistency is scored 8/10 because 94 concerns normalize to 25 issues and validator-reported pairwise overlap reaches 88%. The synthesis is faithful and does not create false consensus, but the raw package is substantially duplicative. The xenograft-host discussion is conditional, and the final synthesis expressly preserves host strain, immune status, and reagent compatibility as `NOT ASSESSABLE`; it is therefore not counted as an unsupported assertion.

### System A, run A2

A2 also detects all 18 answer-key issues. Its 34-issue matrix is more granular than the key, but the extra concerns are supported by the packet or are reasonable editorial/reporting judgments. In particular, the reported Spearman coefficient and P value can be checked from the stated eight-tumour denominator, so flagging their incompatibility is not invention. The package again merits full traceability, resolution, journal-calibration, and auditability scores.

Consistency is 8/10 because 74 concerns normalize to 34 issues, 18 are role-specific, and reviewer overlap reaches 80%. The final verdict is coherent and faithful, but issue proliferation and repeated coverage reduce usability.

### System B, run B1

B1 detects all 18 issues in one final Markdown artifact. Its reviewer-specific concern IDs, claim pointers, evidence pointers, and resolution tests are faithful and sufficiently stable for full traceability and resolution scores. The cross-review synthesis distinguishes shared issues from reviewer-specific emphasis and avoids pretending to make the editorial decision.

Consistency is 9/10: the three reports repeat several central defects, but the final synthesis remains readable and does not manufacture disagreements or consensus. Journal calibration is 9/10 because it applies an appropriate Nature-style originality, importance, interdisciplinary-interest, and technical-soundness bar while reserving final fit to editors. Auditability is 2/5 because there is no frozen-input hash, structured ledger, run metadata, or machine-checkable validation artifact.

### System B, run B2

B2 detects 16 of 18 issues. It misses G16 because it never states the absent hazard-ratio confidence intervals or the untested proportional-hazards assumption; requests for confidence intervals on the three-year AUC or general uncertainty are adjacent but not the core defect. It misses G17 because it discusses pseudoreplication and marks figure encodings, denominators, and uncertainty displays as not assessable, but never states that the one-cell-per-point display and incomplete legend reporting visually obscure the eight-patient biological unit.

G14 is counted as detected because B2 directly identifies reference 1 as inadequate support for the sweeping no-prior-clinical-utility claim. The package does not separately audit reference 2, so this detection is narrower than in the other runs. Scores for traceability, resolution, consistency, journal calibration, and auditability follow the same rationale as B1.

## False positives and unsupported concerns

No unsupported concerns were counted in any run. None alleges duplicated patients, a specific corrected effect direction, CRISPR off-target occurrence, unreported animal sex or welfare events, absent ethical approval, fabricated references, or certain acceptance/rejection. Claims about unavailable figures, source outputs, citation full text, underlying approvals, and xenograft host/reagent suitability are generally bounded as `NOT ASSESSABLE`.

The packages do raise extra concerns beyond G01-G18, including missing infiltration definitions, score dichotomization, incomplete generic test specification, in-vitro replicate reporting, the EVA1-score mechanistic bridge, and the numerical Spearman inconsistency. These are grounded in omissions or contradictions visible in the frozen manuscript and are not false positives under the protocol.

## Replicate stability and usability

System A shows complete observed stability: both runs detect G01-G18, unsupported counts are 0 in both, and both use the same `MAJOR_SCIENTIFIC_REWORK_REQUIRED` posture. The normalized issue overlap is 18/18. The main stability cost is operational rather than scientific: both packages are highly duplicative and contain many more normalized issues than the answer key.

System B shows modest observed variation: B1 detects all 18 issues, while B2 detects 16, with a weighted ground-truth difference of 3/42 and normalized overlap of 16/18. Unsupported counts remain 0, and both runs agree that the manuscript's case is not established and requires major scientific rework. The variation is due to omissions of survival-model diagnostics and figure-level biological-unit reporting, not a contradictory scientific posture.

## Blinded comparative conclusion

System A is the stronger overall benchmark performer because it combines complete recall with the best provenance, machine-checkable traceability, explicit non-assessability boundaries, and journal-profile calibration. Its principal weakness is heavy reviewer duplication and issue proliferation.

System B produces strong, usable reviewer prose with excellent concern-level pointers and closure tests. B1 matches the complete scientific concern set, but the system is less auditable because only final Markdown is present; B2 additionally shows a small recall drop. On these four runs, the blinded evidence favors System A for reproducible review workflow quality and favors System B for a somewhat leaner final-review format, without supporting any universal performance claim beyond this forward test.
